1	4	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Discussion	_	_	NN	_	_	_	_	_
2	and	_	_	CC	_	_	_	_	_
3	Conclusions	_	_	NNS	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	we	_	_	PRP	_	_	_	_	_
6	considered	_	_	VBD	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	following	_	_	VBG	_	_	_	_	_
9	two	_	_	CD	_	_	_	_	_
10	major	_	_	JJ	_	_	_	_	_
11	factors	_	_	NNS	_	_	_	_	_
12	that	_	_	WDT	_	_	_	_	_
13	could	_	_	MD	_	_	_	_	_
14	influence	_	_	VB	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	evolution	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	f8/9	_	_	JJ	_	_	_	_	_
20	landscape	_	_	NN	_	_	_	_	_
21	phage	_	_	NN	_	_	_	_	_
22	library	_	_	NN	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	mice	_	_	NNS	_	_	_	_	_
25	:	_	_	:	_	_	_	_	_
26	(	_	_	-LRB-	_	_	_	_	_
27	1	_	_	CD	_	_	_	_	_
28	)	_	_	-RRB-	_	_	_	_	_
29	its	_	_	PRP$	_	_	_	_	_
30	multidisperse	_	_	NN	_	_	_	_	_
31	characteristics	_	_	NNS	_	_	_	_	_
32	as	_	_	IN	_	_	_	_	_
33	revealed	_	_	VBN	_	_	_	_	_
34	in	_	_	IN	_	_	_	_	_
35	soft	_	_	JJ	_	_	_	_	_
36	agar	_	_	NN	_	_	_	_	_
37	electrophoresis	_	_	NN	_	_	_	_	_
38	and	_	_	CC	_	_	_	_	_
39	(	_	_	-LRB-	_	_	_	_	_
40	2	_	_	CD	_	_	_	_	_
41	)	_	_	-RRB-	_	_	_	_	_
42	organ-	_	_	JJ	_	_	_	_	_
43	and	_	_	CC	_	_	_	_	_
44	tumor-specific	_	_	JJ	_	_	_	_	_
45	targets	_	_	NNS	_	_	_	_	_
46	for	_	_	IN	_	_	_	_	_
47	phage	_	_	NN	_	_	_	_	_
48	binding	_	_	NN	_	_	_	_	_
49	interactions	_	_	NNS	_	_	_	_	_
50	that	_	_	WDT	_	_	_	_	_
51	can	_	_	MD	_	_	_	_	_
52	arise	_	_	VB	_	_	_	_	_
53	from	_	_	IN	_	_	_	_	_
54	organ-	_	_	JJ	_	_	_	_	_
55	or	_	_	CC	_	_	_	_	_
56	tissue-specific	_	_	JJ	_	_	_	_	_
57	gene	_	_	NN	_	_	_	_	_
58	expression	_	_	NN	_	_	_	_	_
59	.	_	_	.	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	showed	_	_	VBD	_	_	_	_	_
3	that	_	_	IN	_	_	_	_	_
4	modified	_	_	VBN	_	_	_	_	_
5	p8	_	_	NN	_	_	_	_	_
6	proteins	_	_	NNS	_	_	_	_	_
7	displaying	_	_	VBG	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	fusion	_	_	NN	_	_	_	_	_
10	peptide	_	_	NN	_	_	_	_	_
11	along	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	length	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	filamentous	_	_	JJ	_	_	_	_	_
17	phage	_	_	NN	_	_	_	_	_
18	particle	_	_	NN	_	_	_	_	_
19	would	_	_	MD	_	_	_	_	_
20	create	_	_	VB	_	_	_	_	_
21	vastly	_	_	RB	_	_	_	_	_
22	different	_	_	JJ	_	_	_	_	_
23	particles	_	_	NNS	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	each	_	_	DT	_	_	_	_	_
26	containing	_	_	VBG	_	_	_	_	_
27	unique	_	_	JJ	_	_	_	_	_
28	physicochemical	_	_	JJ	_	_	_	_	_
29	features	_	_	NNS	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	supporting	_	_	VBG	_	_	_	_	_
32	complex	_	_	JJ	_	_	_	_	_
33	interactions	_	_	NNS	_	_	_	_	_
34	within	_	_	IN	_	_	_	_	_
35	a	_	_	DT	_	_	_	_	_
36	defined	_	_	VBN	_	_	_	_	_
37	microenvironment	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	reflected	_	_	VBN	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	our	_	_	PRP$	_	_	_	_	_
5	in	_	_	FW	_	_	_	_	_
6	vitro	_	_	NN	_	_	_	_	_
7	migration	_	_	NN	_	_	_	_	_
8	study	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	presence	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	random	_	_	JJ	_	_	_	_	_
14	fusion	_	_	NN	_	_	_	_	_
15	peptides	_	_	NNS	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	charged	_	_	VBN	_	_	_	_	_
18	amino	_	_	JJ	_	_	_	_	_
19	acids	_	_	NNS	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	landscape	_	_	NN	_	_	_	_	_
22	phages	_	_	NNS	_	_	_	_	_
23	results	_	_	VBZ	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	significant	_	_	JJ	_	_	_	_	_
26	changes	_	_	NNS	_	_	_	_	_
27	in	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	ionization	_	_	NN	_	_	_	_	_
30	state	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	phage	_	_	NN	_	_	_	_	_
34	particle	_	_	NN	_	_	_	_	_
35	leading	_	_	VBG	_	_	_	_	_
36	to	_	_	TO	_	_	_	_	_
37	differences	_	_	NNS	_	_	_	_	_
38	in	_	_	IN	_	_	_	_	_
39	surface	_	_	NN	_	_	_	_	_
40	charge	_	_	NN	_	_	_	_	_
41	and	_	_	CC	_	_	_	_	_
42	their	_	_	PRP$	_	_	_	_	_
43	subsequent	_	_	JJ	_	_	_	_	_
44	ability	_	_	NN	_	_	_	_	_
45	to	_	_	TO	_	_	_	_	_
46	migrate	_	_	VB	_	_	_	_	_
47	through	_	_	IN	_	_	_	_	_
48	an	_	_	DT	_	_	_	_	_
49	agarose	_	_	NN	_	_	_	_	_
50	gel	_	_	NN	_	_	_	_	_
51	,	_	_	,	_	_	_	_	_
52	demonstrated	_	_	VBN	_	_	_	_	_
53	previously	_	_	RB	_	_	_	_	_
54	with	_	_	IN	_	_	_	_	_
55	isolated	_	_	VBN	_	_	_	_	_
56	clones	_	_	NNS	_	_	_	_	_
57	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	unique	_	_	JJ	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	emergent	_	_	JJ	_	_	_	_	_
5	feature	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	landscape	_	_	NN	_	_	_	_	_
8	phages	_	_	NNS	_	_	_	_	_
9	cannot	_	_	MD	_	_	_	_	_
10	be	_	_	VB	_	_	_	_	_
11	translated	_	_	VBN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	p3-type	_	_	NN	_	_	_	_	_
14	libraries	_	_	NNS	_	_	_	_	_
15	as	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	occurrence	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	p3	_	_	NN	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	only	_	_	RB	_	_	_	_	_
22	five	_	_	CD	_	_	_	_	_
23	copies	_	_	NNS	_	_	_	_	_
24	limits	_	_	VBZ	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	ability	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	a	_	_	DT	_	_	_	_	_
29	displayed	_	_	VBN	_	_	_	_	_
30	fusion	_	_	NN	_	_	_	_	_
31	peptide	_	_	NN	_	_	_	_	_
32	to	_	_	TO	_	_	_	_	_
33	significantly	_	_	RB	_	_	_	_	_
34	change	_	_	VB	_	_	_	_	_
35	the	_	_	DT	_	_	_	_	_
36	physicochemical	_	_	JJ	_	_	_	_	_
37	properties	_	_	NNS	_	_	_	_	_
38	of	_	_	IN	_	_	_	_	_
39	the	_	_	DT	_	_	_	_	_
40	entire	_	_	JJ	_	_	_	_	_
41	particle	_	_	NN	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	can	_	_	MD	_	_	_	_	_
3	be	_	_	VB	_	_	_	_	_
4	envisioned	_	_	VBN	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	local	_	_	JJ	_	_	_	_	_
7	changes	_	_	NNS	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	pH	_	_	NN	_	_	_	_	_
10	within	_	_	IN	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	tissue	_	_	NN	_	_	_	_	_
13	microenvironment	_	_	NN	_	_	_	_	_
14	may	_	_	MD	_	_	_	_	_
15	modify	_	_	VB	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	surface	_	_	NN	_	_	_	_	_
18	charge	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	landscape	_	_	NN	_	_	_	_	_
21	phage	_	_	NN	_	_	_	_	_
22	particles	_	_	NNS	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	exposing	_	_	VBG	_	_	_	_	_
25	a	_	_	DT	_	_	_	_	_
26	previously	_	_	RB	_	_	_	_	_
27	hidden	_	_	VBN	_	_	_	_	_
28	binding	_	_	NN	_	_	_	_	_
29	epitope	_	_	NN	_	_	_	_	_
30	or	_	_	CC	_	_	_	_	_
31	also	_	_	RB	_	_	_	_	_
32	hiding	_	_	VBG	_	_	_	_	_
33	a	_	_	DT	_	_	_	_	_
34	previously	_	_	RB	_	_	_	_	_
35	accessible	_	_	JJ	_	_	_	_	_
36	binding	_	_	VBG	_	_	_	_	_
37	epitope	_	_	NN	_	_	_	_	_
38	allowing	_	_	VBG	_	_	_	_	_
39	enhanced	_	_	VBN	_	_	_	_	_
40	penetration	_	_	NN	_	_	_	_	_
41	or	_	_	CC	_	_	_	_	_
42	retention	_	_	NN	_	_	_	_	_
43	within	_	_	IN	_	_	_	_	_
44	a	_	_	DT	_	_	_	_	_
45	particular	_	_	JJ	_	_	_	_	_
46	microenvironment	_	_	NN	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	Following	_	_	VBG	_	_	_	_	_
2	an	_	_	DT	_	_	_	_	_
3	extensive	_	_	JJ	_	_	_	_	_
4	meta-analysis	_	_	NN	_	_	_	_	_
5	study	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	nanoparticle	_	_	NN	_	_	_	_	_
8	biocompatibility	_	_	NN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	vivo	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	it	_	_	PRP	_	_	_	_	_
13	was	_	_	VBD	_	_	_	_	_
14	concluded	_	_	VBN	_	_	_	_	_
15	that	_	_	IN	_	_	_	_	_
16	functional	_	_	JJ	_	_	_	_	_
17	nanocarriers	_	_	NNS	_	_	_	_	_
18	had	_	_	VBD	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	slightly	_	_	RB	_	_	_	_	_
21	negative	_	_	JJ	_	_	_	_	_
22	surface	_	_	NN	_	_	_	_	_
23	charge	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	moderate	_	_	JJ	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	high	_	_	JJ	_	_	_	_	_
28	solubility	_	_	NN	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	particle	_	_	NN	_	_	_	_	_
32	sizes	_	_	NNS	_	_	_	_	_
33	in	_	_	IN	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	range	_	_	NN	_	_	_	_	_
36	of	_	_	IN	_	_	_	_	_
37	~100	_	_	CD	_	_	_	_	_
38	–	_	_	TO	_	_	_	_	_
39	200	_	_	CD	_	_	_	_	_
40	nm	_	_	NN	_	_	_	_	_
41	in	_	_	IN	_	_	_	_	_
42	diameter	_	_	NN	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	Given	_	_	VBN	_	_	_	_	_
2	that	_	_	IN	_	_	_	_	_
3	landscape	_	_	NN	_	_	_	_	_
4	phage	_	_	NN	_	_	_	_	_
5	libraries	_	_	NNS	_	_	_	_	_
6	display	_	_	VBP	_	_	_	_	_
7	peptide	_	_	NN	_	_	_	_	_
8	fusions	_	_	NNS	_	_	_	_	_
9	that	_	_	WDT	_	_	_	_	_
10	can	_	_	MD	_	_	_	_	_
11	dramatically	_	_	RB	_	_	_	_	_
12	alter	_	_	VB	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	surface	_	_	NN	_	_	_	_	_
15	profile	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	phage	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	we	_	_	PRP	_	_	_	_	_
21	hypothesized	_	_	VBD	_	_	_	_	_
22	that	_	_	IN	_	_	_	_	_
23	libraries	_	_	NNS	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	phage	_	_	NN	_	_	_	_	_
26	particles	_	_	NNS	_	_	_	_	_
27	represent	_	_	VBP	_	_	_	_	_
28	ideal	_	_	JJ	_	_	_	_	_
29	nanoparticle	_	_	NN	_	_	_	_	_
30	systems	_	_	NNS	_	_	_	_	_
31	to	_	_	TO	_	_	_	_	_
32	test	_	_	VB	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	effects	_	_	NNS	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	a	_	_	DT	_	_	_	_	_
37	displayed	_	_	VBN	_	_	_	_	_
38	peptide	_	_	NN	_	_	_	_	_
39	on	_	_	IN	_	_	_	_	_
40	tissue-selective	_	_	JJ	_	_	_	_	_
41	accumulation	_	_	NN	_	_	_	_	_
42	within	_	_	IN	_	_	_	_	_
43	the	_	_	DT	_	_	_	_	_
44	local	_	_	JJ	_	_	_	_	_
45	microenvironment	_	_	NN	_	_	_	_	_
46	while	_	_	IN	_	_	_	_	_
47	maintaining	_	_	VBG	_	_	_	_	_
48	other	_	_	JJ	_	_	_	_	_
49	critical	_	_	JJ	_	_	_	_	_
50	parameters	_	_	NNS	_	_	_	_	_
51	like	_	_	IN	_	_	_	_	_
52	particle	_	_	NN	_	_	_	_	_
53	size	_	_	NN	_	_	_	_	_
54	and	_	_	CC	_	_	_	_	_
55	shape	_	_	NN	_	_	_	_	_
56	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	our	_	_	PRP$	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	we	_	_	PRP	_	_	_	_	_
6	observed	_	_	VBD	_	_	_	_	_
7	similar	_	_	JJ	_	_	_	_	_
8	trends	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	tissue	_	_	NN	_	_	_	_	_
11	accumulation	_	_	NN	_	_	_	_	_
12	as	_	_	IN	_	_	_	_	_
13	reported	_	_	VBN	_	_	_	_	_
14	previously	_	_	RB	_	_	_	_	_
15	for	_	_	IN	_	_	_	_	_
16	p3-type	_	_	NN	_	_	_	_	_
17	libraries	_	_	NNS	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Analysis	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	3-mer	_	_	JJ	_	_	_	_	_
4	frequency	_	_	NN	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	each	_	_	DT	_	_	_	_	_
7	tissue	_	_	NN	_	_	_	_	_
8	revealed	_	_	VBD	_	_	_	_	_
9	that	_	_	IN	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	significant	_	_	JJ	_	_	_	_	_
12	portion	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	motifs	_	_	NNS	_	_	_	_	_
15	were	_	_	VBD	_	_	_	_	_
16	shared	_	_	VBN	_	_	_	_	_
17	across	_	_	IN	_	_	_	_	_
18	all	_	_	DT	_	_	_	_	_
19	tissues	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	leading	_	_	VBG	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	nonspecific	_	_	JJ	_	_	_	_	_
24	uptake	_	_	NN	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	clearance	_	_	NN	_	_	_	_	_
27	or	_	_	CC	_	_	_	_	_
28	had	_	_	VBD	_	_	_	_	_
29	very	_	_	RB	_	_	_	_	_
30	low	_	_	JJ	_	_	_	_	_
31	occurrences	_	_	NNS	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	were	_	_	VBD	_	_	_	_	_
3	able	_	_	JJ	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	identify	_	_	VB	_	_	_	_	_
6	several	_	_	JJ	_	_	_	_	_
7	families	_	_	NNS	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	motifs	_	_	NNS	_	_	_	_	_
10	that	_	_	WDT	_	_	_	_	_
11	were	_	_	VBD	_	_	_	_	_
12	enriched	_	_	VBN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	a	_	_	DT	_	_	_	_	_
15	tissue-selective	_	_	JJ	_	_	_	_	_
16	manner	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Some	_	_	DT	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	identified	_	_	VBN	_	_	_	_	_
5	motifs	_	_	NNS	_	_	_	_	_
6	corresponded	_	_	VBD	_	_	_	_	_
7	with	_	_	IN	_	_	_	_	_
8	previously	_	_	RB	_	_	_	_	_
9	identified	_	_	VBN	_	_	_	_	_
10	tissue-selective	_	_	JJ	_	_	_	_	_
11	motifs	_	_	NNS	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	identified	_	_	VBD	_	_	_	_	_
5	many	_	_	JJ	_	_	_	_	_
6	motifs	_	_	NNS	_	_	_	_	_
7	that	_	_	WDT	_	_	_	_	_
8	were	_	_	VBD	_	_	_	_	_
9	not	_	_	RB	_	_	_	_	_
10	reported	_	_	VBN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	suggesting	_	_	VBG	_	_	_	_	_
13	that	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	type	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	peptide	_	_	NN	_	_	_	_	_
18	display	_	_	NN	_	_	_	_	_
19	will	_	_	MD	_	_	_	_	_
20	have	_	_	VB	_	_	_	_	_
21	a	_	_	DT	_	_	_	_	_
22	significant	_	_	JJ	_	_	_	_	_
23	effect	_	_	NN	_	_	_	_	_
24	on	_	_	IN	_	_	_	_	_
25	tissue	_	_	NN	_	_	_	_	_
26	accumulation	_	_	NN	_	_	_	_	_
27	or	_	_	CC	_	_	_	_	_
28	pharmacokinetics	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	underlying	_	_	JJ	_	_	_	_	_
3	hypothesis	_	_	NN	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	our	_	_	PRP$	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	vivo	_	_	NN	_	_	_	_	_
8	evolution	_	_	NN	_	_	_	_	_
9	study	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	landscape	_	_	NN	_	_	_	_	_
12	phages	_	_	NNS	_	_	_	_	_
13	is	_	_	VBZ	_	_	_	_	_
14	based	_	_	VBN	_	_	_	_	_
15	on	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	assumption	_	_	NN	_	_	_	_	_
18	that	_	_	IN	_	_	_	_	_
19	tissue-specific	_	_	JJ	_	_	_	_	_
20	gene	_	_	NN	_	_	_	_	_
21	expression	_	_	NN	_	_	_	_	_
22	provides	_	_	VBZ	_	_	_	_	_
23	a	_	_	DT	_	_	_	_	_
24	context-dependent	_	_	JJ	_	_	_	_	_
25	pathway	_	_	NN	_	_	_	_	_
26	for	_	_	IN	_	_	_	_	_
27	development	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	tissue	_	_	NN	_	_	_	_	_
30	specificity	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	tissue-specific	_	_	JJ	_	_	_	_	_
3	gene	_	_	NN	_	_	_	_	_
4	expression	_	_	NN	_	_	_	_	_
5	profiles	_	_	NNS	_	_	_	_	_
6	provide	_	_	VBP	_	_	_	_	_
7	transcriptional	_	_	JJ	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	translational	_	_	JJ	_	_	_	_	_
10	control	_	_	NN	_	_	_	_	_
11	for	_	_	IN	_	_	_	_	_
12	tissue-specific	_	_	JJ	_	_	_	_	_
13	synthesis	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	corresponding	_	_	VBG	_	_	_	_	_
16	proteins	_	_	NNS	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	their	_	_	PRP$	_	_	_	_	_
19	underlying	_	_	JJ	_	_	_	_	_
20	protein-domain	_	_	JJ	_	_	_	_	_
21	networks	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	was	_	_	VBD	_	_	_	_	_
3	suggested	_	_	VBN	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	components	_	_	NNS	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	these	_	_	DT	_	_	_	_	_
8	protein-domain	_	_	JJ	_	_	_	_	_
9	networks	_	_	NNS	_	_	_	_	_
10	could	_	_	MD	_	_	_	_	_
11	be	_	_	VB	_	_	_	_	_
12	identified	_	_	VBN	_	_	_	_	_
13	through	_	_	IN	_	_	_	_	_
14	in	_	_	FW	_	_	_	_	_
15	vitro	_	_	FW	_	_	_	_	_
16	or	_	_	CC	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	vivo	_	_	NN	_	_	_	_	_
19	targeted	_	_	VBN	_	_	_	_	_
20	evolution	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	EBU/SLiM-harboring	_	_	JJ	_	_	_	_	_
23	phage	_	_	NN	_	_	_	_	_
24	displayed	_	_	VBN	_	_	_	_	_
25	peptide	_	_	NN	_	_	_	_	_
26	libraries	_	_	NNS	_	_	_	_	_
27	such	_	_	JJ	_	_	_	_	_
28	as	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	multivalent	_	_	JJ	_	_	_	_	_
31	landscape	_	_	NN	_	_	_	_	_
32	phage	_	_	NN	_	_	_	_	_
33	library	_	_	NN	_	_	_	_	_
34	used	_	_	VBN	_	_	_	_	_
35	in	_	_	IN	_	_	_	_	_
36	this	_	_	DT	_	_	_	_	_
37	project	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	accordance	_	_	NN	_	_	_	_	_
3	with	_	_	IN	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	hypothesis	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	we	_	_	PRP	_	_	_	_	_
8	identified	_	_	VBD	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	following	_	_	VBG	_	_	_	_	_
11	three	_	_	CD	_	_	_	_	_
12	major	_	_	JJ	_	_	_	_	_
13	types	_	_	NNS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	EBU	_	_	NN	_	_	_	_	_
16	motifs	_	_	NNS	_	_	_	_	_
17	:	_	_	:	_	_	_	_	_
18	(	_	_	-LRB-	_	_	_	_	_
19	1	_	_	CD	_	_	_	_	_
20	)	_	_	-RRB-	_	_	_	_	_
21	motifs	_	_	NNS	_	_	_	_	_
22	common	_	_	JJ	_	_	_	_	_
23	for	_	_	IN	_	_	_	_	_
24	all	_	_	DT	_	_	_	_	_
25	tissues	_	_	NNS	_	_	_	_	_
26	;	_	_	:	_	_	_	_	_
27	(	_	_	-LRB-	_	_	_	_	_
28	2	_	_	CD	_	_	_	_	_
29	)	_	_	-RRB-	_	_	_	_	_
30	motifs	_	_	NNS	_	_	_	_	_
31	specific	_	_	JJ	_	_	_	_	_
32	for	_	_	IN	_	_	_	_	_
33	organs	_	_	NNS	_	_	_	_	_
34	with	_	_	IN	_	_	_	_	_
35	functionally	_	_	RB	_	_	_	_	_
36	related	_	_	JJ	_	_	_	_	_
37	tissues	_	_	NNS	_	_	_	_	_
38	and	_	_	CC	_	_	_	_	_
39	similar	_	_	JJ	_	_	_	_	_
40	correlated	_	_	VBN	_	_	_	_	_
41	patterns	_	_	NNS	_	_	_	_	_
42	of	_	_	IN	_	_	_	_	_
43	co-expressed	_	_	VBN	_	_	_	_	_
44	genes	_	_	NNS	_	_	_	_	_
45	;	_	_	:	_	_	_	_	_
46	and	_	_	CC	_	_	_	_	_
47	(	_	_	-LRB-	_	_	_	_	_
48	3	_	_	CD	_	_	_	_	_
49	)	_	_	-RRB-	_	_	_	_	_
50	motifs	_	_	NNS	_	_	_	_	_
51	unique	_	_	JJ	_	_	_	_	_
52	to	_	_	TO	_	_	_	_	_
53	single	_	_	JJ	_	_	_	_	_
54	tissues	_	_	NNS	_	_	_	_	_
55	with	_	_	IN	_	_	_	_	_
56	unique	_	_	JJ	_	_	_	_	_
57	functions	_	_	NNS	_	_	_	_	_
58	,	_	_	,	_	_	_	_	_
59	which	_	_	WDT	_	_	_	_	_
60	may	_	_	MD	_	_	_	_	_
61	be	_	_	VB	_	_	_	_	_
62	related	_	_	VBN	_	_	_	_	_
63	to	_	_	TO	_	_	_	_	_
64	tissue-specific	_	_	JJ	_	_	_	_	_
65	gene	_	_	NN	_	_	_	_	_
66	expression	_	_	NN	_	_	_	_	_
67	profiles	_	_	NNS	_	_	_	_	_
68	within	_	_	IN	_	_	_	_	_
69	the	_	_	DT	_	_	_	_	_
70	tissues	_	_	NNS	_	_	_	_	_
71	or	_	_	CC	_	_	_	_	_
72	to	_	_	TO	_	_	_	_	_
73	specific	_	_	JJ	_	_	_	_	_
74	physical	_	_	JJ	_	_	_	_	_
75	features	_	_	NNS	_	_	_	_	_
76	of	_	_	IN	_	_	_	_	_
77	the	_	_	DT	_	_	_	_	_
78	local	_	_	JJ	_	_	_	_	_
79	microenvironment	_	_	NN	_	_	_	_	_
80	.	_	_	.	_	_	_	_	_


1	Here	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	demonstrated	_	_	VBD	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	frequencies	_	_	NNS	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	several	_	_	JJ	_	_	_	_	_
10	3-mer	_	_	JJ	_	_	_	_	_
11	motifs	_	_	NNS	_	_	_	_	_
12	are	_	_	VBP	_	_	_	_	_
13	shared	_	_	VBN	_	_	_	_	_
14	across	_	_	IN	_	_	_	_	_
15	all	_	_	DT	_	_	_	_	_
16	tissue	_	_	NN	_	_	_	_	_
17	types	_	_	NNS	_	_	_	_	_
18	(	_	_	-LRB-	_	_	_	_	_
19	Figure	_	_	NN	_	_	_	_	_
20	5	_	_	CD	_	_	_	_	_
21	A	_	_	DT	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	black	_	_	JJ	_	_	_	_	_
24	arrow	_	_	NN	_	_	_	_	_
25	)	_	_	-RRB-	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	can	_	_	MD	_	_	_	_	_
28	be	_	_	VB	_	_	_	_	_
29	representative	_	_	JJ	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	interactions	_	_	NNS	_	_	_	_	_
32	with	_	_	IN	_	_	_	_	_
33	protein	_	_	NN	_	_	_	_	_
34	products	_	_	NNS	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	“	_	_	``	_	_	_	_	_
37	housekeeping-like	_	_	JJ	_	_	_	_	_
38	”	_	_	''	_	_	_	_	_
39	genes	_	_	NNS	_	_	_	_	_
40	expressed	_	_	VBN	_	_	_	_	_
41	at	_	_	IN	_	_	_	_	_
42	constant	_	_	JJ	_	_	_	_	_
43	levels	_	_	NNS	_	_	_	_	_
44	across	_	_	IN	_	_	_	_	_
45	all	_	_	DT	_	_	_	_	_
46	tissue	_	_	NN	_	_	_	_	_
47	types	_	_	NNS	_	_	_	_	_
48	,	_	_	,	_	_	_	_	_
49	such	_	_	JJ	_	_	_	_	_
50	as	_	_	IN	_	_	_	_	_
51	those	_	_	DT	_	_	_	_	_
52	involved	_	_	VBN	_	_	_	_	_
53	in	_	_	IN	_	_	_	_	_
54	metabolism	_	_	NN	_	_	_	_	_
55	.	_	_	.	_	_	_	_	_


1	Similar	_	_	JJ	_	_	_	_	_
2	patterns	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	motif	_	_	NN	_	_	_	_	_
5	enrichment	_	_	NN	_	_	_	_	_
6	could	_	_	MD	_	_	_	_	_
7	be	_	_	VB	_	_	_	_	_
8	identified	_	_	VBN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	tissues	_	_	NNS	_	_	_	_	_
11	with	_	_	IN	_	_	_	_	_
12	functionally-related	_	_	JJ	_	_	_	_	_
13	roles	_	_	NNS	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	gene	_	_	NN	_	_	_	_	_
16	expression	_	_	NN	_	_	_	_	_
17	patterns	_	_	NNS	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	can	_	_	MD	_	_	_	_	_
3	be	_	_	VB	_	_	_	_	_
4	visualized	_	_	VBN	_	_	_	_	_
5	by	_	_	IN	_	_	_	_	_
6	enrichment	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	similar	_	_	JJ	_	_	_	_	_
9	motifs	_	_	NNS	_	_	_	_	_
10	patterns	_	_	NNS	_	_	_	_	_
11	between	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	liver	_	_	NN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	spleen	_	_	NN	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	25	_	_	CD	_	_	_	_	_
18	significantly	_	_	RB	_	_	_	_	_
19	enriched	_	_	VBN	_	_	_	_	_
20	motifs	_	_	NNS	_	_	_	_	_
21	being	_	_	VBG	_	_	_	_	_
22	shared	_	_	VBN	_	_	_	_	_
23	between	_	_	IN	_	_	_	_	_
24	both	_	_	DT	_	_	_	_	_
25	tissues	_	_	NNS	_	_	_	_	_
26	(	_	_	-LRB-	_	_	_	_	_
27	Figure	_	_	NN	_	_	_	_	_
28	5	_	_	CD	_	_	_	_	_
29	A	_	_	NN	_	_	_	_	_
30	)	_	_	-RRB-	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	organs	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	expected	_	_	VBN	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	contain	_	_	VB	_	_	_	_	_
7	cell	_	_	NN	_	_	_	_	_
8	types	_	_	NNS	_	_	_	_	_
9	or	_	_	CC	_	_	_	_	_
10	structures	_	_	NNS	_	_	_	_	_
11	within	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	local	_	_	JJ	_	_	_	_	_
14	microenvironment	_	_	NN	_	_	_	_	_
15	that	_	_	WDT	_	_	_	_	_
16	have	_	_	VBP	_	_	_	_	_
17	common	_	_	JJ	_	_	_	_	_
18	biological	_	_	JJ	_	_	_	_	_
19	functions	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	representing	_	_	VBG	_	_	_	_	_
22	a	_	_	DT	_	_	_	_	_
23	theoretical	_	_	JJ	_	_	_	_	_
24	construct	_	_	NN	_	_	_	_	_
25	for	_	_	IN	_	_	_	_	_
26	targeting	_	_	VBG	_	_	_	_	_
27	to	_	_	TO	_	_	_	_	_
28	a	_	_	DT	_	_	_	_	_
29	multi-organ	_	_	JJ	_	_	_	_	_
30	system	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Finally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	demonstrated	_	_	VBD	_	_	_	_	_
5	motif	_	_	NN	_	_	_	_	_
6	enrichment	_	_	NN	_	_	_	_	_
7	within	_	_	IN	_	_	_	_	_
8	single	_	_	JJ	_	_	_	_	_
9	tissues	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	including	_	_	VBG	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	tumor	_	_	NN	_	_	_	_	_
14	xenograft	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	which	_	_	WDT	_	_	_	_	_
17	suggests	_	_	VBZ	_	_	_	_	_
18	there	_	_	EX	_	_	_	_	_
19	are	_	_	VBP	_	_	_	_	_
20	tissue-specific	_	_	JJ	_	_	_	_	_
21	genes	_	_	NNS	_	_	_	_	_
22	that	_	_	WDT	_	_	_	_	_
23	are	_	_	VBP	_	_	_	_	_
24	overexpressed	_	_	VBN	_	_	_	_	_
25	or	_	_	CC	_	_	_	_	_
26	structures	_	_	NNS	_	_	_	_	_
27	in	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	microenvironment	_	_	NN	_	_	_	_	_
30	that	_	_	WDT	_	_	_	_	_
31	allow	_	_	VBP	_	_	_	_	_
32	for	_	_	IN	_	_	_	_	_
33	tissue-selective	_	_	JJ	_	_	_	_	_
34	accumulation	_	_	NN	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	phages	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	demonstrated	_	_	VBN	_	_	_	_	_
4	by	_	_	IN	_	_	_	_	_
5	3-mer	_	_	JJ	_	_	_	_	_
6	motifs	_	_	NNS	_	_	_	_	_
7	like	_	_	IN	_	_	_	_	_
8	“	_	_	``	_	_	_	_	_
9	MYW	_	_	NNP	_	_	_	_	_
10	”	_	_	''	_	_	_	_	_
11	that	_	_	WDT	_	_	_	_	_
12	are	_	_	VBP	_	_	_	_	_
13	only	_	_	RB	_	_	_	_	_
14	enriched	_	_	VBN	_	_	_	_	_
15	within	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	tumor	_	_	NN	_	_	_	_	_
18	microenvironment	_	_	NN	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	suggested	_	_	VBD	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	play	_	_	VB	_	_	_	_	_
23	a	_	_	DT	_	_	_	_	_
24	role	_	_	NN	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	selective	_	_	JJ	_	_	_	_	_
27	binding	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	a	_	_	DT	_	_	_	_	_
30	tumor-specific	_	_	JJ	_	_	_	_	_
31	marker	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_

